Property | Value |
?:abstract
|
-
Most severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in pediatric patients are mild or asymptomatic. However, infants have emerged at higher risk of hospitalization and severe outcomes in pediatric coronavirus disease 2019 (COVID-19). We report a case series of 4 full-term neonates hospitalized with fever and found to have SARS-CoV-2 infection with a spectrum of illness severities. Two neonates required admission to the intensive care unit for respiratory insufficiency and end organ involvement. Half of the patients were found to have a coinfection. One neonate received antiviral therapy with remdesivir and is, to our knowledge, the youngest patient to receive this drug for COVID-19. All neonates had favorable outcomes.
|
?:creator
|
|
?:doi
|
|
?:doi
|
|
?:journal
|
-
J_Pediatric_Infect_Dis_Soc
|
?:license
|
|
?:pdf_json_files
|
-
document_parses/pdf_json/1633f2dec34b95bdb6c165c32c8d7c180f08c6fe.json
|
?:pmc_json_files
|
-
document_parses/pmc_json/PMC7454701.xml.json
|
?:pmcid
|
|
?:pmid
|
|
?:pmid
|
|
?:publication_isRelatedTo_Disease
|
|
?:sha_id
|
|
?:source
|
|
?:title
|
-
Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Febrile Neonates
|
?:type
|
|
?:year
|
|